Revolutionary Intelligence for Disease Diagnostics
Capturing the Power of Artificial Intelligence to Combat Disease
Affordable life-saving capabilities of AI and Visual diagnostics are brought together in a disruptive, single-visit, point-of-care technology solution for Examination, Screening, Triage, and Treatment (ESTT) of cervical and gastroenterological lesions and cancers
Meets Worldwide Demand for Improved Health Protection that Eliminates Global Disparity
Provides cost-effective solutions in support of World Health Organization (WHO) and Cancer Moonshot goals for cervical cancer elimination and other lifesaving improvements
Key Market Factors
- The global cost of cervical cancer is expected to increase to $682B between 2020 and 2050
- Updated colonoscopy guidelines lower screening age to 45, generating millions of new patients
- Company’s affordable technology vital to overseas development and NGO programs to improve health care disparity
- Also key to meeting WHO global cervical cancer goals for 70% screening coverage and 90% precancerous legion treatment/invasive cancer management
- Low capital and software costs enables rapid market penetration strategy
aiv technology is vital to changing clinical Practice
Cancer Screening Protocols are Evolving
As laboratory-based cancer screening methods and intervals change, the need for an annual doctor visit remains a constant of wellness. Company's AIV technology multiples the capability of the basic pelvic exam to include detection, classification, and recorded visual results that can be the basis for further screening, triage, and treatment (ESTT) as needed.
The Growing Need For Simplified, High-Quality Surveillance Capability
As medicine tracks newly emerging high regression rates in pre-cancerous cervical cells, clinical practice increasingly is transitioning to active surveillance as a component of treatment. Company's breakthrough AIV technology enables AI assisted video tracking of disease progression, providing optimal surveillance for high-grade patient care that avoids unnecessary, potentially harmful, and costly excision treatments.
The Market is Ready and Waiting
As medical care and treatment expands through the world, best and more cost-effective technolgies will be needed to meet growing healthcare demands of world populations twenty-five times that of the US. An established medical device company will be able to guide sales of Company's AIV technology to the $400 to $500 million range in a few years and create a market value of $5 billion or more.
Tackling Cancer Treatment Disparities
Lifesaving Features
Lifesaving Features
Lifesaving Features
- Low cost (≤ $10 per screening) for patients, providers, insurers and public payer programs
- Automated report reducing overall operation time by 30%
- Video features improve record keeping and sharing
- Objective and consistent results meeting highest levels of tissue abnormality classification standards
- AIV systems for eight different screening and diagnostic applications.
Established Success
Lifesaving Features
Lifesaving Features
- $4.3 million in government-supported R&D projects
- 7 clinical trials conducted
- Operating in 15 countries including distributor and direct sales
- Hard- and software certifications in 9 countries, including US, Japan, and Indonesia, with agreements pending in six more
- 16 domestic and overseas patents with 33 pending
- Multiple published journal articles evaluating technology development and use
Cervical ESTT
Gastroenterological STT
Gastroenterological STT
- Single visit examination provides recorded results in 2-3 minutes to screen, surveil, triage, and optimize treatment
- Higher accuracy than Pap smear (over 90% sensitivity and specificity)
- Portability and integrated telemedicine/online consultation capabilities access markets in remote or underserved areas
Gastroenterological STT
Gastroenterological STT
Gastroenterological STT
- Only AI solution providing 6-stage classification for gastric cancer detection
- AI-based real-time detection system for stomach and colon endoscopy
- Compatible and easily attachable with most endoscope systems
- Realtime detection with high speed video (>30 fps)
- Image Auto-Adjustment & Freeze Action Detection
A Unique Acquisition Opportunity
If You Are a Company That...
- Understands strategic pricing and penetration for healthcare in N. America and Europe, as well as Asian, African, and S. American Low/Middle Income Countries
- Has existing OB-Gyn and gastroenterology device and servicing marketing and sales capability that is looking to expand revenue beyond current projections
- Desires a market capitalization value in the range of $5 billion in just a few years….